Subsequently, our study demonstrated that Notch1 downregulation could significantly inhibit glioma initiating cell biological behavior including self-renewal invasion and migration in vitro, as well as tumor growth in vivo. This evidence concerns the gene NOTCH1 and central nervous system cancer.